Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Bone Marrow Transplant. 2019 Jan 29;54(9):1443–1452. doi: 10.1038/s41409-019-0455-y

Table 3.

Outcome estimates by final PACT score

Outcomea Final PACT score
P-value
Poor (score 0–1, N = 21) Acceptable (score 2, N = 87) Good (score 3, N = 177) Excellent (score 4, N = 119)
Overall survival at 1-yeara 57 [34–75] 60 [49–69] 59 [52–66] 67 [58–75] 0.11
Non-relapse mortality at 1-yearb 33 [14–54] 24 [16–34] 27 [21–34] 16 [10–23] 0.03
Relapse at 1-yearb 24 [8–44] 30 [21–40] 24 [18–31] 25 [18–33] 0.90
Grade II-IV acute GVHD at 100 daysb 48 [25–67] 32 [23–42] 44 [38–45] 34 [26–43] 0.72
Chronic GVHD at 1 yearb 38 [17–59] 37 [27–47] 30 [23–37] 38 [29–46] 0.76
Duration of index hospitalizationc 35 [29–42] 29 [25–40] 30 [24–39] 29 [23–38] 0.17
Days alive and out of hospital in the first 100-daysc 58 [45–70] 65 [44–78] 66 [45–77] 70 [54–79] 0.07

[ ] indicates range

GVHD Graft-versus-host disease

a

Kaplan–Meier estimate with 95% confidence intervals

b

Cumulative incidence estimate with 95% confidence intervals

c

Median with inter-quartile range